Table 1: Baseline characteristics of patients with FMF.

Patients

Age at diagnosis, (years)*23.1 ± 12.8
Duration of illness, (years)*6.6 ± 7.3
Family history of FMF, ( , %)54 (57.4)/42 (42.6)
Dose of colchicine, (mg/day)*1.43 ± 0.55
Response to colchicine, ( , %)88 (93.6)/6 (6.4)
Scoring system of Pras et al. [10] (mild, moderate, severe)5.44 ± 2.27
Fever, ( , %)87 (92.6)
Peritonitis, ( , %)87 (92.6)
Pleuritis, ( , %)58 (61.7)
Pericarditis, ( , %)8 (8.5)
Arthritis, ( , %)16 (17)
Arthralgia, ( , %)55 (58.5)
Myalgia, ( , %)44 (46.8)
Erysipelas-like erythema, ( , %)6 (6.4)
MEFV mutations, ( , %)
Homozygous M694V9 (9.6)
Heterozygous M694V26 (27.7)
Heterozygous M680I11 (11.7)
Heterozygous E148Q11 (11.7)
Heterozygous V726A4 (4.3)
Heterozygous M694V/M680I4 (4.3)
Heterozygous M694V/E148Q3 (3.2)
Others26 (27.7)

Mean ± SD; [10] is reference number in the references section.